Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/06/026039
CTRI/2020/06/026039
Not yet recruiting
未知

CANCER care in COVID-19 ERAâ?? A prospective survey to study the preferences and perspectives of patients with hematological malignancies in a tertiary cancer care setting in India. (CANCOV SURVEY) - CanCov Survey Study

I0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue
Sponsor
I
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients under evaluation for a suspected hematological malignancy or with a diagnosis of hematological malignancy (acute and chronic leukemias, lymphomas, myeloma, and others) will be included in the study.
  • •2\. Patients who are planned for or receiving chemotherapy / immunotherapy / targeted therapy in the OPD, ward, daycare and ICU will be eligible.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Perspective of cancer patient in COVID-19 pandemicHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/10/028438nil
Completed
Not Applicable
Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care ResearchColorectal Cancer (CRC) and Pancreatic Cancer (PaCa)
NCT05479292Technische Universität Dresden6,500
Completed
Not Applicable
The Impact of COVID-19 Pandemic on Cancer CareCancer
NCT04382495El Zaitoun Specialized Hospital300
Unknown
Not Applicable
COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including BiobankingCancerCOVID
NCT04408339Universitätsklinikum Hamburg-Eppendorf500
Completed
Phase 3
C-SMART.COVID-19 Prevention and Treatment in Cancer. Arm 3: treatment among cancer patients with moderate COVID-19 infection.
ACTRN12620000841976Peter MacCallum Cancer Centre3